Literature DB >> 15962980

The reactions of nitrosyl complexes with cysteine.

Federico Roncaroli1, José A Olabe.   

Abstract

The reaction kinetics of a set of ruthenium nitrosyl complexes, {(X)5MNO}n, containing different coligands X (polypyridines, NH3, EDTA, pz, and py) with cysteine (excess conditions), were studied by UV-vis spectrophotometry, using stopped-flow techniques, at an appropriate pH, in the range 3-10, and T = 25 degrees C. The selection of coligands afforded a redox-potential range from -0.3 to +0.5 V (vs Ag/AgCl) for the NO+/NO bound couples. Two intermediates were detected. The first one, I1, appears in the range 410-470 nm for the different complexes and is proposed to be a 1:1 adduct, with the S atom of the cysteinate nucleophile bound to the N atom of nitrosyl. The adduct formation step of I1 is an equilibrium, and the kinetic rate constants for the formation and dissociation of the corresponding adducts were determined by studying the cysteine-concentration dependence of the formation rates. The second intermediate, I2, was detected through the decay of I1, with a maximum absorbance at ca. 380 nm. From similar kinetic results and analyses, we propose that a second cysteinate adds to I1 to form I2. By plotting ln k1(RS-) and ln k2(RS-) for the first and second adduct formation steps, respectively, against the redox potentials of the NO+/NO couples, linear free energy plots are obtained, as previously observed with OH- as a nucleophile. The addition rates for both processes increase with the nitrosyl redox potentials, and this reflects a more positive charge at the electrophilic N atom. In a third step, the I2 adducts decay to form the corresponding Ru-aqua complexes, with the release of N2O and formation of cystine, implying a two-electron process for the overall nitrosyl reduction. This is in contrast with the behavior of nitroprusside ([Fe(CN)5NO]2-; NP), which always yields the one-electron reduction product, [Fe(CN)5NO]3-, either under substoichiometric or in excess-cysteine conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962980     DOI: 10.1021/ic048156d

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

1.  The Preparation, Structural Characteristics, and Physical Chemical Properties of Metal-Nitrosyl Complexes.

Authors:  Lauren R Holloway; Lijuan Li
Journal:  Struct Bond       Date:  2013-05-29       Impact factor: 1.176

2.  Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors.

Authors:  Jean Jerley N Silva; Wander R Pavanelli; José Clayston M Pereira; João S Silva; Douglas W Franco
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

3.  Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity.

Authors:  Jean Jerley Nogueira Silva; Paulo Marcos Matta Guedes; Aderson Zottis; Tatiane Luciano Balliano; Francisco Ordelei Nascimento Silva; Luiz Gonzaga França Lopes; Javier Ellena; Glaucius Oliva; Adriano Defini Andricopulo; Douglas Wagner Franco; João Santana Silva
Journal:  Br J Pharmacol       Date:  2010-01-26       Impact factor: 8.739

4.  In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.

Authors:  J J N Silva; A L Osakabe; W R Pavanelli; J S Silva; D W Franco
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

5.  A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity.

Authors:  Edinilton Muniz Carvalho; Lisa A Ridnour; Florêncio Sousa Gouveia Júnior; Pedro Henrique Bezerra Cabral; Nilberto Robson Falcão do Nascimento; David A Wink; Douglas W Franco; Mayara Jane Campos de Medeiros; Daniel de Lima Pontes; Elisane Longhinotti; Tércio de Freitas Paulo; Vania Bernardes-Génisson; Remi Chauvin; Eduardo Henrique Silva Sousa; Luiz Gonzaga de França Lopes
Journal:  J Inorg Biochem       Date:  2020-06-20       Impact factor: 4.155

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.